Therapy Areas: Vaccines
China's CanSino Biologics COVID-19 vaccine shows high antibody levels in Russian trials
14 January 2021 -

Russia's Interfax news agency reported on Thursday that Russian biopharmaceutical company Petrovax has said that 92.5% of Russian volunteers in trials of the Chinese Ad5-Ncov vaccine against COVID-19 had shown high levels of antibodies.

Reportedly, Ad5-nCoV is a candidate vaccine co-developed by Chinese vaccine company CanSino Biologics and a Chinese military-backed research unit.